Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

MMIT Reality Check on Viscosupplements (May 2017)

Posted by Matt Breese on May 17, 2017

Find me on:

According to our recent payer coverage analysis for viscosupplements, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Payer Coverage: A look at market access over the past two quarters shows a market correction for commercial lives, where the amount of unrestricted lives increased significantly. However, step therapy and PA policies became more restrictive overall.

mmit-reality-check-visco-q2.png

Source: MMIT data as of Q2 2017

Trends:  Recent news related to viscosupplementation shows the divide between prescribers, who continue to adopt visco treatments, and surgeons, who prefer the alternative of knee replacement. However, the viscosupplementation market continues to grow at a rapid pace.

To read the full Reality Check on viscosupplements with key findings on clinical characteristics, visco drug market access and payer coverage, please click on the button below: 

reality-check-thumbnail-v1-1.png

View Reality Check

 

Topics: Specialty, Market Access, Branding & Marketing